# Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Source: https://onco.cc/trials/nct07441369/  
OnCo record `nct07441369` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of abemaciclib, fOLFOX (5-FU, leucovorin, oxaliplatin), leucovorin (folinic acid), fluorouracil (5-FU) and other drugs in colorectal cancer, run by Fudan University, now recruiting.

## Summary

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer is a phase 2, interventional study registered as NCT07441369 by Fudan University, with a registry enrolment figure of 16 participants, started 2026-07-30 and due to reach its primary completion in 2027-04-30. Interventions recorded: Abemaciclib; Oxaliplatin; Calcium Folinate; 5-Fluorouracil; Irinotecan. Conditions listed: Liver Metastases From Colorectal Cancer (mCRC). Primary outcome: ORR. Colorectal eligibility wording from the registry: "Histologically or cytologically confirmed unresectable advanced colorectal liver metastases cancer". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07441369
- Phase: 2
- Setting: Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Two or Three-line Therapy
- Sponsor: Fudan University
- Enrolled: 16

## Sources

- ClinicalTrials.gov NCT07441369: https://clinicaltrials.gov/study/NCT07441369

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/), [Topoisomerase-I inhibitors (and ADC payloads)](https://onco.cc/technologies/topoisomerase-inhibitors/)
- drugs: [Abemaciclib](https://onco.cc/drugs/abemaciclib/), [Fluorouracil (5-FU)](https://onco.cc/drugs/fluorouracil/), [FOLFIRI (5-FU, leucovorin, irinotecan)](https://onco.cc/drugs/folfiri/), [FOLFOX (5-FU, leucovorin, oxaliplatin)](https://onco.cc/drugs/folfox/), [Leucovorin (folinic acid)](https://onco.cc/drugs/leucovorin/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07441369.json